Transcript of Earnings Call held on July 21, 2026

Date: July 28, 2026 The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C/1, G-Block Dalal Street Bandra-Kurla Complex Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code:544282 Symbol: SAGILITY Dear Sir/Ma’am, Subject: Transcript of Investors Call held on July 21, 2026 This is in continuation of the Investors/Analyst Webinar conducted on July 21, 2026, to discuss the unaudited financial results of the Company for the quarter ended June 30, 2026. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby attach the transcript of the aforementioned webinar. This information is also available on the Company’s website https://sagility.com/ This is for your kind information and record. Thanking You, For Sagility Limited Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer M.No. A16008 Encl: a/a Sagility Limited (Formerly Sagility India Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru – 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Sagility Ltd. Q1 FY27 Earnings Conference Call Transcript Tuesday, 21st July, 2026 at 7:30 pm MANAGEMENT • Ramesh Gopalan - Managing Director & Group CEO • Srinivas Rathnam Mattapalli - Executive Vice President and Group Chief Financial Officer MODERATOR • Siddharth Rangnekar - CDR India QUESTIONERS • Akshat Agarwal – Jefferies • Baidik Sarkar - Unifi Capital • Rohit Thorat - Axis Capital • Vamshi Krishna - Kotak Securities • Rishi Jhunjhunwala – IIFL Capital • Seema Nayak - ICICI Securities • Sameer Pardikar - Elara Capital • Rishabh Mehra - Demeter Advisors • Arvind Arora - A Square Advisors Siddharth Rangnekar: Good evening and welcome to the quarter one FY 2027 Earnings Webinar of Sagility Limited. This is Siddharth Rangnekar from CDR India and I shall be your host for today. As a reminder all lines will be in the listen-only mode and there shall be an opportunity for you to ask questions after the presentation concludes. Please note that this webinar is being recorded. To introduce the management, we have with us today, Mr. Ramesh Gopalan, Managing Director and Group CEO; Mr. Srinivas Mattapalli, Executive Vice President and Group Chief Financial Officer. Before we begin, I would like to state that some of the statements made on today's call could be forward-looking in nature and may involve certain risks and uncertainties. A detailed statement in this regard is available in the quarter one FY 2027 results presentation that has been uploaded to the exchanges. I would now like to hand over the forum to Mr. Ramesh to begin the proceedings of this webinar. Over to you. Ramesh Gopalan: Thank you, Siddharth. Good evening, everyone, and thank you for joining us for our Q1 FY 2027 earnings call. We are pleased to report a strong start to FY 2027. Our Q1 performance reflects the continued relevance of our healthcare focused operating model, the depth of our client relationships, and the disciplined executions of our teams across geographies. Before I get into the quarter’s performance in more detail, let me briefly comment on the market context. U.S. healthcare organisations continue to operate in an environment where margin protection, cost discipline, and medical utilisation management remain critical priorities. While select payers have reported slightly improved or lower medical utilisation, the broader market continues to see pressure from rising utilisation, like medical costs, increasing regulatory complexity, and membership volatility. In this context, leading payers are prioritising margin recovery, clinical and care management effectiveness, stars performance, and focused administrative cost reduction initiatives. Against this backdrop, demand continues to favour partners that combine deep healthcare domain expertise with operational scale, technology, analytics, AI and a demonstrated ability to deliver measurable outcomes. And this aligns very well with our strategic direction of moving beyond fragmented process-led models towards more integrated, outcome driven operating frameworks that bring together domain expertise, technology and AI, operational execution, and accountability for results. And we are starting to see traction with clients for managed service deals constructs, where we take operational ownership of, an accountability for a Page | 2 large part of the value chain and deliver committed outcomes at a much lower cost. We are also making inroads with Sagility Synchrony, our AI-led orchestration platform, connecting fragmented workflows across claims and adjustments, enabling faster decisions, greater operational visibility, and improved outcomes. Our other strategic priorities are increasing our capabilities in the healthcare value chain and expanding in the mid- and small-market segments. Our CareSeed acquisition helps us on both these fronts, strengthening our capabilities in the quality area, especially for Medicare Advantage plans, and giving us 26 additional clients in the mid- and small-segment. I'll cover CareSeed in detail in the subsequent slides. So with that, let's quickly jump into specifics for Q1. We entered FY 2027 following a successful open enrolment season, during which our teams delivered consistently across key payer programs in one of the most operationally demanding periods for our clients. As seasonal volumes normalised, we carried that momentum into Q1. The growth during the quarter was led by expansion within existing client relationships, with FY 2026 client additions beginning to scale and contribute more meaningfully, supported by sustained demand across higher value service lines. Sagility delivered a strong start to FY 2027. Revenue for the quarter was INR 19,635 million, or $207.8 million, representing 27.6% year-on-year growth and 15.2% growth in constant currency. Organic growth, excluding CareSeed acquisition, was strong at 27.3% in INR terms and 14.9% in constant currency. Sequentially, reported revenue declined versus Q4, reflecting the seasonal impact of open enrolment and AEP volumes that we support in Q3 and Q4. Excluding the seasonality, steady state organic revenue grew 5.1% quarter-on- quarter from $197.3 million to $207.3 million. Importantly, these seasonal revenues are recurring, and we expect the usual uptick again in Q3 and Q4 of FY 2027. On the profitability front, Q1 adjusted EBITDA was INR 4,716 million, or $49.9 million, growing 27.9% year-on-year with a margin of 24%. Adjusted PAT increased to INR 2,697 million, or $28.6 million, up 35.1% year-on-year with a margin of 13.7%. This margin performance was delivered while implementing our annual salary increases effective April 2026 and absorbing the impact of an increase in statutory minimum wage in Karnataka and Telangana. The increase in minimum wages in Karnataka was pretty significant, and so absorbing this reflects the strength and flexibility of our operating model. And MR will cover more details about this minimum wage impact in his section. Page | 3 Turning to new wins, our commercial momentum remained healthy with $35.3 million of steady state ACV signed during the quarter across 18 existing clients and 1 new logo. Before we move ahead, I want to take a moment to highlight the external recognition we earned during the quarter, an endorsement of our talent proposition, as well as our differentiated market positioning. On the workplace front, Great Place to Work India ranks Sagility 11th amongst the country's 100 best companies to work for in 2026, and this was our first year of enrolling in the survey. ET Edge recognised us among the best organisations for wo [Showing first 8,000 characters — download PDF for full document]